HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 20 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 534,000 | $3,103,000 | 2.10% |
| Cowen Prime Advisors LLC | 570,333 | $3,314,000 | 1.20% |
| Cowen Prime Services LLC | 570,333 | $3,314,000 | 1.20% |
| AIGH Capital Management LLC | 612,000 | $3,556,000 | 0.64% |
| Blue Water Life Science Advisors, LP | 144,881 | $841,000 | 0.32% |
| Worth Venture Partners, LLC | 143,135 | $832,000 | 0.31% |
| Nantahala Capital Management | 363,622 | $2,113,000 | 0.06% |
| HighMark Wealth Management LLC | 6,966 | $40,000 | 0.03% |
| PDT Partners, LLC | 15,501 | $90,000 | 0.01% |
| Advisory Services Network, LLC | 3,700 | $21,000 | 0.00% |